![]() MetaStat MetaStat, Inc. develops and commercializes diagnostic tests for risk of cancer metastasis, companion diagnostics and anti-metastatic drugs. | ![]() Salarius Pharmaceuticals Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments. | ![]() Immutep Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment. | |
Founding Date | Founding Date 2010 | Founding Date 2011 | Founding Date 2001 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Boston, US HQ | Locations Houston, US HQ | Locations Sydney, AU HQ Sydney, AU The Rocks, AU Orsay, FR Berlin, DE Leipzig, DE |
Employees | Employees 6 | Employees 2 | Employees 2427% decrease |
Valuation ($) | Valuation ($) 20.6 k | Valuation ($) 2.4 m | Valuation ($) 282.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) $23.3k (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($3.2m) (FY, 2018) | Net income N/A | Net income ($61.4m) (FY, 2025) |

Salarius Pharmaceuticals is a clinical-stage biotechnology company developing epigenetic-based cancer treatments.
View company
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
View company